Projected Earnings Date: 2025-05-13    (Delayed quote data   2025-04-04)
Last
 59.13
Change
 ⇓ -8.66   (-12.77%)
Volume
  11,807,497
Open
 59.91
High
 61.38
Low
 56.18
8EMA (Daily)
 70.49
40EMA (Daily)
 76.07
50EMA (Daily)
 76.61
STO (Daily)
 27.293
MACD Hist (Daily)
 -2.856
8EMA (Weekly)
 73.153
40EMA (Weekly)
 77.88
50EMA (Weekly)
 77.81
STO (Weekly)
 25.462
MACD Hist (Weekly)
 -3.210
E. I. du Pont de Nemours and Company operates as a science and technology based company worldwide. Its Agriculture segment provides corn hybrid, soybean, canola, sunflower, sorghum, inoculants, wheat, and rice seed products under the Pioneer brand; and herbicides, fungicides, and insecticides. The company?s Electronics and Communications segment supplies materials and systems, including photopolymers and electronic materials for photovoltaic products, consumer electronics, displays, and advanced printing. The Industrial Biosciences segment develops and manufactures a portfolio of enzymes. The Nutrition and Health segment offers cultures, emulsifiers, gums, natural sweeteners, and soy-based food ingredients. The Performance Chemicals segment offers industrial and specialty chemical products for markets, including plastics and coatings, textiles, mining, pulp and paper, water treatment, and healthcare; titanium dioxide products; and industrial and specialty fluorochemicals, fluoropolymers, and performance chemicals. The Performance Materials segment provides thermoplastic and thermoset engineering polymers, elastomers, films, parts, and systems and solutions for the automotive original equipment manufacturers and associated after-market industries, as well as electrical, electronics, packaging, construction, oil, photovoltaics, aerospace, chemical processing, and consumer durable goods. The Safety and Protection segment primarily offers nonwovens, aramids, and solid surfaces for the construction, transportation, communications, industrial chemicals, oil and gas, electric utilities, automotive, manufacturing, defense, homeland security, and safety consulting industries. The Pharmaceuticals segment represents its interest in the collaboration relating to Cozaar/Hyzaar antihypertensive drugs. The company was founded in 1802 and is headquartered in Wilmington, Delaware.
optionchance optionchance
Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com